2017
DOI: 10.1080/09712119.2017.1284075
|View full text |Cite
|
Sign up to set email alerts
|

Effect of two routes of administration of human chorionic gonadotropin upon oestrus induction and reproductive outcomes in adult acyclic mix-breed goats

Abstract: Deras (2018) Effect of two routes of administration of human chorionic gonadotropin upon oestrus induction and reproductive outcomes in adult acyclic mix-breed goats,

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
5
2

Year Published

2019
2019
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 9 publications
(9 citation statements)
references
References 26 publications
2
5
2
Order By: Relevance
“…Gonadotropin releasing hormone (GnRH) or human chorionic gonadotropin (hCG) injections are applied to improve the reproductive performance in anestrus goats (Medan et al, 2002;Rodríguez-Martínez et al, 2018). A strategy of reproductive performance included inducing estrus and ovulation (Cameron et al, 1988;Khan et al, 2003;González-Álvarez et al 2016).The hCG has an activity similar to luteinizing hormone (LH), while the GnRH acts on the pituitary gland, stimulates the release of LH and FSH and subsequently the secretion of steroid hormones from the gonads.…”
Section: Introductionmentioning
confidence: 99%
“…Gonadotropin releasing hormone (GnRH) or human chorionic gonadotropin (hCG) injections are applied to improve the reproductive performance in anestrus goats (Medan et al, 2002;Rodríguez-Martínez et al, 2018). A strategy of reproductive performance included inducing estrus and ovulation (Cameron et al, 1988;Khan et al, 2003;González-Álvarez et al 2016).The hCG has an activity similar to luteinizing hormone (LH), while the GnRH acts on the pituitary gland, stimulates the release of LH and FSH and subsequently the secretion of steroid hormones from the gonads.…”
Section: Introductionmentioning
confidence: 99%
“…Goats in both management conditions were treated with an injectable P4 plus hCG-based protocol as previously described by Rodríguez-Martínez et al (2018). Briefly, goats were injected with 20 mg of P4 in oil adjuvant (0.4 mL/goat, Progesterona, Zoetis, Mexico), plus 100 IU of hCG (0.1 mL/ goat, Chorulon, Intervet, Mexico) 24 h later, administered by the intramuscular route and applied in the morning.…”
Section: Methodsmentioning
confidence: 99%
“…Progestogens are usually administered using intravaginal devices, including silicone-based devices impregnated with progesterone (P4), such as Controlled Internal Drug Release (CIDR) and Dispositivo Intravaginal Caprino Ovino (DICO) ( Wheaton et al, 1993 ; Vilariño et al, 2010 ), or, intravaginal sponges (IVS) impregnated with progesterone analogues, as medroxyprogesterone acetate (MAP) or flurogestone acetate (FGA) ( Barrett et al, 2008 ; Santos et al, 2010 ). There are some preliminary studies on the administration of long-acting injectable progesterone ( Rodríguez-Martínez et al, 2018 ; Alvarado-Espino et al, 2019 ; Amaral D’Avila et al, 2022 ; Payan et al, 2022 ), but the results are still inconsistent. Until now, sponges impregnated with MAP have been used for the resynchronization protocol ( Miranda et al, 2018 ; Cosentino et al, 2019 , 2021 , 2022 ), but to the best of our knowledge, there are no studies with other progestogens.…”
Section: General Aspectsmentioning
confidence: 99%